Valuation: SIGA Technologies, Inc.

Market Cap 223M 193M 182M 166M 310M 21.37B 312M 2.18B 842M 10.84B 837M 818M 34.54B P/E 2026 *
62x
P/E 2027 * 2.87x
Enterprise Value 105M 90.73M 85.75M 77.85M 146M 10.04B 147M 1.02B 396M 5.09B 393M 385M 16.24B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 0.46x
Free-Float
57.27%
Yield 2026 *
19.4%
Yield 2027 * 19.4%
1 day+4.03%
1 week+0.65%
Current month-1.27%
1 month+3.33%
3 months-27.91%
6 months-43.22%
Current year-49.26%
1 week 2.93
Extreme 2.93
3.16
1 month 2.88
Extreme 2.88
3.32
Current year 2.83
Extreme 2.83
7.1
1 year 2.83
Extreme 2.83
9.45
3 years 2.83
Extreme 2.83
12.83
5 years 2.83
Extreme 2.83
26.99
10 years 1.9
Extreme 1.9
26.99
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-26
Director of Finance/CFO 55 2011-02-09
Chief Operating Officer - 2019-12-31
Director TitleAgeSince
Director/Board Member 73 2009-03-10
Director/Board Member 72 2020-06-15
Director/Board Member 42 2020-12-09
Date Insider Type Main position Quantity % Market Cap. Importance
3/25/26 Exercice

General Counsel

17,366 0.0243%
3/13/26 Exercice

General Counsel

121,769 0.1700%
3/13/26 Exercice

Chief Technology Officer

81,787 0.1142%
Change 5-day change 1-year change 3-year change Capi.($)
+4.03%+0.65%-65.52%-32.17% 223M
+0.15%+1.21%+48.79%+97.65% 1,014B
+0.03%+0.07%+51.47%+65.55% 644B
-0.20%+4.62%+21.39%+72.57% 464B
+0.53%+4.26%+40.29%+38.70% 354B
+0.39%+2.35%+17.96%+23.87% 265B
+0.17%+4.17%+6.96%+10.93% 253B
+0.19%-3.81%+37.81%+44.35% 203B
-1.20%-5.64%-24.09%-59.10% 186B
+0.94%+1.39%+33.21%+95.16% 183B
Average +0.50%+0.93%+16.83%+35.75% 356.7B
Weighted average by Cap. +0.11%+1.41%+34.37%+59.76%

Financials

2026 *2027 *
Net sales 59.86M 51.88M 49.03M 44.51M 83.43M 5.74B 83.93M 585M 226M 2.91B 225M 220M 9.28B 162M 140M 133M 121M 226M 15.55B 227M 1.58B 612M 7.88B 609M 595M 25.13B
Net income 3.72M 3.22M 3.05M 2.77M 5.18M 357M 5.22M 36.38M 14.06M 181M 13.97M 13.66M 577M 77.88M 67.5M 63.79M 57.92M 109M 7.47B 109M 762M 294M 3.79B 293M 286M 12.08B
Net Debt -118M -102M -96.68M -87.77M -165M -11.32B -165M -1.15B -446M -5.74B -443M -434M -18.31B -148M -128M -121M -110M -206M -14.19B -207M -1.45B -559M -7.2B -556M -543M -22.94B
Logo SIGA Technologies, Inc.
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Employees
49
Date Price Change Volume
26-09-16 US$3.100 +4.03% 811,869
26-09-15 US$2.980 -5.40% 480,092
26-09-14 US$3.150 +3.96% 522,908
26-09-11 US$3.030 +0.33% 453,372
26-09-10 US$3.020 -1.95% 550,419
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SIGA Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!